Tesaro Announces FDA Approval of Zejula (niraparib) for Women with Recurrent Ovarian Cancer

Article Link: Tesaro Announces FDA Approval of Zejula (niraparib) for Women with Recurrent Ovarian Cancer



Source: FDA New Drug Approvals